{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:50:33Z","timestamp":1788285033954,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T00:00:00Z","timestamp":1436572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00330-015-3877-y","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T21:14:24Z","timestamp":1436562864000},"page":"683-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Feasibility of measuring renal blood flow by phase-contrast magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease"],"prefix":"10.1007","volume":"26","author":[{"given":"E. M.","family":"Spithoven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Borns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. E.","family":"Boertien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A. J. M.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kappert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J. W.","family":"Greuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"van der Jagt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. E.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. T.","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,11]]},"reference":[{"key":"3877_CR1","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ (2008) Clinical practice. autosomal dominant polycystic kidney disease. N Engl J Med 359:1477\u201385","journal-title":"N Engl J Med"},{"key":"3877_CR2","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O et al (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367:2407\u201318","journal-title":"N Engl J Med"},{"key":"3877_CR3","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","volume":"382","author":"A Caroli","year":"2013","unstructured":"Caroli A, Perico N, Perna A et al (2013) Effect of long-acting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): A randomised, placebo-controlled, multicentre trial. Lancet 382:1485\u201395","journal-title":"Lancet"},{"key":"3877_CR4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"JJ Grantham","year":"2011","unstructured":"Grantham JJ, Mulamalla S, Swenson-Fields KI (2011) Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 7:556\u201366","journal-title":"Nat Rev Nephrol"},{"key":"3877_CR5","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Torres VE, Chapman AB et al (2006) Volume progression in polycystic kidney disease. N Engl J Med 354:2122\u201330","journal-title":"N Engl J Med"},{"key":"3877_CR6","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.2003.00326.x","volume":"64","author":"BF King","year":"2003","unstructured":"King BF, Torres VE, Brummer ME et al (2003) Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. Kidney Int 64:2214\u201321","journal-title":"Kidney Int"},{"key":"3877_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2215\/CJN.00910306","volume":"2","author":"VE Torres","year":"2007","unstructured":"Torres VE, King BF, Chapman AB et al (2007) Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2:112\u201320","journal-title":"Clin J Am Soc Nephrol"},{"key":"3877_CR8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ndt\/gfi304","volume":"21","author":"I Ergun","year":"2006","unstructured":"Ergun I, Keven K, Uruc I et al (2006) The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant 21:697\u2013700","journal-title":"Nephrol Dial Transplant"},{"key":"3877_CR9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.berh.2012.07.008","volume":"26","author":"EJ Bernstein","year":"2012","unstructured":"Bernstein EJ, Schmidt-Lauber C, Kay J (2012) Nephrogenic systemic fibrosis: A systemic fibrosing disease resulting from gadolinium exposure. Best Pract Res Clin Rheumatol 26:489\u2013503","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3877_CR10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncpneph0660","volume":"3","author":"JG Penfield","year":"2007","unstructured":"Penfield JG, Reilly RF Jr (2007) What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 3:654\u201368","journal-title":"Nat Clin Pract Nephrol"},{"key":"3877_CR11","first-page":"97","volume":"20","author":"AJ Donker","year":"1977","unstructured":"Donker AJ, van der Hem GK, Sluiter WJ, Beekhuis H (1977) A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 20:97\u2013103","journal-title":"Neth J Med"},{"key":"3877_CR12","first-page":"F726","volume":"261","author":"C Battilana","year":"1991","unstructured":"Battilana C, Zhang HP, Olshen RA, Wexler L, Myers BD (1991) PAH extraction and estimation of plasma flow in diseased human kidneys. Am J Physiol 261:F726\u201333","journal-title":"Am J Physiol"},{"key":"3877_CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei Y, Obaji J, Dupuis A et al (2009) Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20:205\u201312","journal-title":"J Am Soc Nephrol"},{"key":"3877_CR14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u201312","journal-title":"Ann Intern Med"},{"key":"3877_CR15","unstructured":"Levey AS, Greene T, Kusek J, Beck GJ A simplified equation to predict glomerular filtration rate for serum creatinine [abstract]. 2000:11:115A."},{"key":"3877_CR16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00004728-200007000-00019","volume":"24","author":"KT Bae","year":"2000","unstructured":"Bae KT, Commean PK, Lee J (2000) Volumetric measurement of renal cysts and parenchyma using MRI: Phantoms and patients with polycystic kidney disease. J Comput Assist Tomogr 24:614\u20139","journal-title":"J Comput Assist Tomogr"},{"key":"3877_CR17","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s003300000362","volume":"10","author":"MW Haan de","year":"2000","unstructured":"de Haan MW, Kouwenhoven M, Kessels AG, van Engelshoven JM (2000) Renal artery blood flow: Quantification with breath-hold or respiratory triggered phase-contrast MR imaging. Eur Radiol 10:1133\u20137","journal-title":"Eur Radiol"},{"key":"3877_CR18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.RVI.0000161144.98350.28","volume":"16","author":"L Bax","year":"2005","unstructured":"Bax L, Bakker CJ, Klein WM, Blanken N, Beutler JJ, Mali WP (2005) Renal blood flow measurements with use of phase-contrast magnetic resonance imaging: Normal values and reproducibility. J Vasc Interv Radiol 16:807\u201314","journal-title":"J Vasc Interv Radiol"},{"key":"3877_CR19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/mrm.22278","volume":"63","author":"S Dambreville","year":"2010","unstructured":"Dambreville S, Chapman AB, Torres VE et al (2010) Renal arterial blood flow measurement by breath-held MRI: Accuracy in phantom scans and reproducibility in healthy subjects. Magn Reson Med 63:940\u201350","journal-title":"Magn Reson Med"},{"key":"3877_CR20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1681\/ASN.V74567","volume":"7","author":"AJ Apperloo","year":"1996","unstructured":"Apperloo AJ, de Zeeuw D, Donker AJ, de Jong PE (1996) Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol 7:567\u201372","journal-title":"J Am Soc Nephrol"},{"key":"3877_CR21","first-page":"209","volume":"14","author":"AC Cameron","year":"1996","unstructured":"Cameron AC, Windmeijer FAG (1996) R-squared measures for count data regression models with applications to health-care utilization. J Bus Econ Stat 14:209\u201320","journal-title":"J Bus Econ Stat"},{"key":"3877_CR22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1148\/radiology.208.3.9722853","volume":"208","author":"G Sommer","year":"1998","unstructured":"Sommer G, Corrigan G, Fredrickson J et al (1998) Renal blood flow: Measurement in vivo with rapid spiral MR imaging. Radiology 208:729\u201334","journal-title":"Radiology"},{"key":"3877_CR23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2214\/ajr.161.5.8273644","volume":"161","author":"RL Wolf","year":"1993","unstructured":"Wolf RL, King BF, Torres VE, Wilson DM, Ehman RL (1993) Measurement of normal renal artery blood flow: Cine phase-contrast MR imaging vs clearance of p-aminohippurate. AJR Am J Roentgenol 161:995\u20131002","journal-title":"AJR Am J Roentgenol"},{"key":"3877_CR24","author":"M Cutajar","year":"2015","unstructured":"Cutajar M, Hilton R, Olsburgh J et al (2015) Renal blood flow using arterial spin labelling MRI and calculated filtration fraction in healthy adult kidney donors pre-nephrectomy and post-nephrectomy. Eur Radiol. doi: 10.1007\/s00330-015-3594-6","journal-title":"Eur Radiol"},{"key":"3877_CR25","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.diii.2013.06.010","volume":"94","author":"JC Ferre","year":"2013","unstructured":"Ferre JC, Bannier E, Raoult H, Mineur G, Carsin-Nicol B, Gauvrit JY (2013) Arterial spin labeling (ASL) perfusion: Techniques and clinical use. Diagn Interv Imaging 94:1211\u201323","journal-title":"Diagn Interv Imaging"},{"key":"3877_CR26","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s00330-014-3130-0","volume":"24","author":"M Cutajar","year":"2014","unstructured":"Cutajar M, Thomas DL, Hales PW, Banks T, Clark CA, Gordon I (2014) Comparison of ASL and DCE MRI for the non-invasive measurement of renal blood flow: Quantification and reproducibility. Eur Radiol 24:1300\u20138","journal-title":"Eur Radiol"},{"key":"3877_CR27","unstructured":"Anonymous (12\/23\/2010) FDA drug safety communication: New warnings for using gadolinium-based contrast agents in patients with kidney dysfunction. : http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm223966.htm"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-015-3877-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-015-3877-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-015-3877-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T23:23:08Z","timestamp":1652829788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-015-3877-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,11]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3877"],"URL":"https:\/\/doi.org\/10.1007\/s00330-015-3877-y","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,11]]}}}